Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1984-5-17
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0091-2700
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6-18
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6368615-Clinical Trials as Topic,
pubmed-meshheading:6368615-Drug Industry,
pubmed-meshheading:6368615-Great Britain,
pubmed-meshheading:6368615-Humans,
pubmed-meshheading:6368615-Legislation, Drug,
pubmed-meshheading:6368615-Licensure,
pubmed-meshheading:6368615-Pharmaceutical Preparations
|
pubmed:year |
1984
|
pubmed:articleTitle |
A regulatory view of the Medicines Act in the United Kingdom.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|